Effects of novel chalcone derivatives on α-glucosidase, dipeptidyl peptidase-4, and adipocyte differentiation in vitro
![]() ![]() |
Bak, Eun-Jung
(Oral Cancer Research Institute, Yonsei University College of Dentistry)
Park, Hong-Gyu (Atgc Biotechnology Co., Ltd.) Lee, Choong-Hwan (ATGen Co., Ltd.) Lee, Tong-Il (ATGen Co., Ltd.) Woo, Gye-Hyeong (Department of Clinical Laboratory Science, Semyung University) Na, Young-Hwa (College of Pharmacy, CHA University) Yoo, Yun-Jung (Department of Oral Biology, BK21 Project, Oral Science Research Center, Research Center for Orofacial Hard Tissue Regeneration, Yonsei University College of Dentistry) Cha, Jeong-Heon (Oral Cancer Research Institute, Yonsei University College of Dentistry) |
1 | Cho, K. W., Lee, O. H., Banz, W. J., Moustaid-Moussa, N., Shay, N. F. and Kim, Y. C. (2010) Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activity. J. Nutr. Biochem. 21, 841-847. DOI ScienceOn |
2 | Shin, D. W., Kim, S. N., Lee, S. M., Lee, W., Song, M. J., Park, S. M., Lee, T. R., Baik, J. H., Kim, H. K., Hong, J. H. and Noh, M. (2009) (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation. Biochem. Pharmacol. 77, 125-133. DOI ScienceOn |
3 | Tanaka-Amino, K., Matsumoto, K., Hatakeyama, Y., Shima, I., Takakura, S. and Muto, S. (2008) ASP4,000, a novel, selective, dipeptidyl peptidase 4 inhibitor with antihyperglycemic activity. Eur. J. Pharmacol. 590, 444-449. DOI ScienceOn |
4 | Lee, J. S., Suh, J. M., Park, H. G., Bak, E. J., Yoo, Y. J. and Cha, J. H. (2008) Heparin-binding epidermal growth factor-like growth factor inhibits adipocyte differentiation at commitment and early induction stages. Differentiation 76, 478-487. DOI ScienceOn |
5 | Bak, E. J., Park, H. G., Kim, J. M., Yoo, Y. J. and Cha, J. H. (2010) Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes. Int. J. Obes. (Lond) 34, 250-260. DOI ScienceOn |
6 | Drucker, D. J. and Nauck, M. A. (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696-1705. DOI ScienceOn |
7 | Haraguchi, H., Ishikawa, H., Mizutani, K., Tamura, Y. and Kinoshita, T. (1998) Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med. Chem. 6, 339-347. DOI ScienceOn |
8 | Deacon, C. F., Nauck, M. A., Toft-Nielsen, M., Pridal, L., Willms, B. and Holst, J. J. (1995) Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes 44, 1126-1131. DOI ScienceOn |
9 | Deacon, C. F., Danielsen, P., Klarskov, L., Olesen, M. and Holst, J. J. (2001) Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs. Diabetes 50, 1588-1597. DOI ScienceOn |
10 | Park, W. J. (1998) Effect of epibrassinolide on hypocotyl growth of the tomato mutant diageotropica. Planta 207, 120-124. DOI |
11 | Haraguchi, H., Tanimoto, K., Tamura, Y., Mizutani, K. and Kinoshita, T. (1998) Mode of antibacterial action of retrochalcones from Glycyrrhiza inflata. Phytochemistry 48, 125-129. DOI ScienceOn |
12 | Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I. and Matsuzawa, Y. (2001) PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099. DOI ScienceOn |
13 | Staels, B. and Fruchart, J. C. (2005) Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54, 2460-2470. DOI ScienceOn |
14 | Caspary, W. F. (1978) Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor. Lancet 1, 1231-1233. |
15 | Zimmet, P., Alberti, K. G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature 414, 782-787. DOI ScienceOn |
16 | Astrup, A. and Finer, N. (2000) Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'? Obes. Rev. 1, 57-59. DOI ScienceOn |
17 | Kahn, B. B. and Flier, J. S. (2000) Obesity and insulin resistance. J. Clin. Invest 106, 473-481. DOI ScienceOn |
18 | Syiem, D., Syngai, G., Khup, P. Z., Khongwir, B. S., Kharbuli, B. and Kayang, H. (2002) Hypoglycemic effects of Potentilla fulgens L in normal and alloxan-induced diabetic mice. J. Ethnopharmacol. 83, 55-61. DOI ScienceOn |
19 | Ratner, R. E. (2001) Controlling postprandial hyperglycemia. Am. J. Cardiol. 88, 26H-31H. DOI ScienceOn |
20 | Lebovitz, H. E. (1997) alpha-Glucosidase inhibitors. Endocrinol. Metab. Clin. North. Am. 26, 539-551. DOI |
21 | Youn, J. Y., Park, H. Y. and Cho, K. H. (2004) Anti-hyperglycemic activity of Commelina communis L.: inhibition of alpha-glucosidase. Diabetes Res. Clin. Pract. 66 (Suppl 1), S149-155. DOI ScienceOn |
22 | Li, Y., Wen, S., Kota, B. P., Peng, G., Li, G. Q., Yamahara, J. and Roufogalis, B. D. (2005) Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J. Ethnopharmacol. 99, 239-244. DOI ScienceOn |
23 | Creutzfeldt, W. and Ebert, R. (1985) New developments in the incretin concept. Diabetologia 28, 565-573. DOI |
24 | Zander, M., Madsbad, S., Madsen, J. L. and Holst, J. J. (2002) Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 359, 824-830. DOI ScienceOn |
![]() |